1. Naeini FF, Najafian J, Ahmadpour K. Bleomycin tattooing as a promising therapeutic modality in large keloids and hypertrophic scars. Dermatol Surg 2006;32(8):1023-30. [
DOI:10.1111/j.1524-4725.2006.32225.x]
3. Shaldoum DR, Hassan GF, El Maadawy EH, El‐Maghraby GM. Comparative clinical study of the efficacy of intralesional MMR vaccine vs intralesional vitamin D injection in treatment of warts. J Cosmet Dermatol 2020;19(8):2033-40. [
DOI:10.1111/jocd.13272]
5. El Sayed MH, Sayed FS, Afify AA. Intralesional zinc sulfate 2% vs intralesional vitamin D in plantar warts: A clinicodermoscopic study. Dermatol Ther 2020;33(3):e13308. [
DOI:10.1111/dth.13308]
7. Kelemen O, Kollár L. Current methods of treatment and prevention of pathologic scars. Magy Seb 2007;60(2):63-70. [
DOI:10.1556/maseb.60.2007.2.1]
9. Ledon JA, Savas J, Franca K, Chacon A, Nouri K. Intralesional treatment for keloids and hypertrophic scars: a review. Dermatol Surg 2013;39(12):1745-57. [
DOI:10.1111/dsu.12346]
11. Draaijers LJ, Tempelman FR, Botman YA, Tuinebreijer WE, Middelkoop E, Kreis RW, et al. The patient and observer scar assessment scale: a reliable and feasible tool for scar evaluation. Plast Reconst Surg 2004;113(7):1960-5. [
DOI:10.1097/01.PRS.0000122207.28773.56]
13. Gauglitz GG, Korting HC, Pavicic T, Ruzicka T, Jeschke MG. Hypertrophic scarring and keloids: pathomechanisms and current and emerging treatment strategies. Mol Med 2011;17(1):113-25. [
DOI:10.2119/molmed.2009.00153]
15. Shaffer JJ, Taylor SC, Cook-Bolden F. Keloidal scars: a review with a critical look at therapeutic options. JAAD 2002;46(2):S63-S97. [
DOI:10.1067/mjd.2002.120788]
17. Saray Y, Güleç AT. Treatment of keloids and hypertrophic scars with dermojet injections of bleomycin: a preliminary study. Int J Dermatol 2005;44(9):777-84. [
DOI:10.1111/j.1365-4632.2005.02633.x]
19. Wang R, Mao Y, Zhang Z, Li Z, Chen J, Cen Y. Role of verapamil in preventing and treating hypertrophic scars and keloids. Int Wound J 2016;13(4):461-8. [
DOI:10.1111/iwj.12455]
21. Zhang GY, Cheng T, Luan Q, Liao T, Nie CL, Zheng X, et al. Vitamin D: a novel therapeutic approach for keloid, an in vitro analysis. Br J Dermatol 2011; 164:729-37. [
DOI:10.1111/j.1365-2133.2010.10130.x]
23. Ramirez AM, Wongtrakool C, Welch T, Steinmeyer A, Zügel U, Roman J. Vitamin D inhibition of pro-fibrotic effects of transforming growth factor β1 in lung fibroblasts and epithelial cells. JSBBEZ 2010;118(3):142-50. [
DOI:10.1016/j.jsbmb.2009.11.004]
25. Damanik VI, Putra IB, Ginting O. Correlation between serum 25-hydroxyvitamin D levels with keloid severity. Maced J Med Sci 2019;7(1):65. [
DOI:10.3889/oamjms.2019.022]
27. Mamdouh M, Omar GA, Hafiz HS, Ali SM. Role of vitamin D in treatment of keloid. J Cosmet Dermatol 2022;21(1):331-6. [
DOI:10.1111/jocd.14070]
29. Ahuja RB, Chatterjee P. Comparative efficacy of intralesional verapamil hydrochloride and triamcinolone acetonide in hypertrophic scars and keloids. Burns 2014;40(4):583-8. [
DOI:10.1016/j.burns.2013.09.029]